Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Clin Appl Thromb Hemost. 2013 May 7;20(4):385–392. doi: 10.1177/1076029613486537

Table 1.

Patient Demographics and Responses to Survey Questions.

ASA+ INT− ASA+ INT+ p ASA− INT+ ASA− INT− p
n 31 25 24 27
Male, n (%) 11 (35) 7 (28) .55 8 (33) 14 (52) .18
Age, mean ± SD 62 ± 4.3 61 ± 7.2 .51 58 ± 4.1 59 ± 6.6 .34
Diabetes, n (%) 2 (6) 3 (12) .65 0 (0) 1 (4) 1.00
Smoking, n (%) 1 (3) 1 (4) 1.00 1 (4) 1 (4) 1.00
Use aspirin regularly for the prevention of cardiovascular disease, n (%) 29 (94) 19 (76) .12 0 (0) 1 (4) 1.00
Used aspirin
 In the past 24 hours, n (%) 29 (94) 22 (88) .65 0 (0) 0 (0) NA
 In the past 7 days, n (%) 31 (100) 25 (100) NA 0 (0) 0 (0) NA
Used pain medication
 In the past 24 hours, n (%) 1 (3) 13 (52) <.0001 9 (38) 1 (4) .004
 In the past 7 days, n (%) 3 (10) 22 (88) <.0001 21 (88) 1 (4) <.0001
Used cold, flu, or allergy medication
 In the past 24 hours, n (%) 0 (0) 11 (44) <.0001 7 (29) 0 (0) .003
 In the past 7 days, n (%) 0 (0) 11 (44) <.0001 12 (50) 0 (0) <.0001
Used NSAID
 In the past 24 hours, n (%) 0 (0) 7 (28) .002 5 (21) 0 (0) .018
 In the past 7 days, n (%) 0 (0) 21 (84) <.0001 17 (71) 0 (0) <.0001

Abbreviations: ASA, aspirin; INT, possible interfering medication; NSAID, nonsteroidal anti-inflammatory drug; n, number; SD, standard deviation; NA, not applicable.